COVID-19 Shutdowns in China: Infiniti Research Explains What This Means for the Global Pharmaceutical Supply Chain

LONDON–(BUSINESS WIRE)–#COVID19–Infiniti Research is the world’s leading independent provider of strategic market intelligence solutions. Our market intelligence services are designed to connect your organization’s goals with global opportunities. Today’s international business environment demands in-depth, accurate, and reliable local business information to ensure that global companies gain a strong foothold in foreign markets. Our global industry specialist teams ensure the international consistency of our research, enabling powerful access to the real story behind consumer change.

Pharma manufacturing companies across the globe are heavily dependent on active pharmaceutical ingredients (APIs) from China. APIs are included in numerous lifesaving drugs, making coronavirus a real threat not only for the commercial world but also for patients around the globe. According to pharma industry experts at Infiniti Research, some of the implications of this crisis on the global pharmaceutical supply chain would include:

• Although supply chain disruptions have not yet manifested as most companies keep API buffers, there are chances that due to the present situation inventories might run low shortly. This could have adverse effects on countries including the US, India, Germany, Netherlands, and Brazil which are the largest importers of drugs from China.
• The FDA in the US reports that bottlenecks in the drug supply chain will lead to a shortage of over 100 prescription drugs.
• Indian authorities claim that there is already a rise of over 20% in the price of APIs due to a shortage of essential drugs.
• As India accounts for nearly 20% of the global pharmaceuticals production in terms of volume, chances of supply chain disruptions to spill over to the rest of the world are highly likely.

Request a free proposal for key insights and strategies on how to adapt your business operations to thrive amidst the existing global crisis.

Several major pharmaceutical companies around the globe remain optimistic in their efforts to support drug development for the novel coronavirus. Some of them are even collaborating with other biopharmaceutical companies to produce a COVID-19 vaccine. But there is still immense scope for drug research and testing that remains unexplored. Infiniti’s team of industry experts use a proven methodology that leverages our proprietary forecast models, have access to high-quality internal and external published content, and information gained from primary research interviews. With over 15+ years of expertise, we have developed a strong network of key opinion leaders and subject matter experts who partner with us to develop futuristic insights. For more insights on how we can help with your research and drug development efforts, get in touch with us.

About Infiniti Research

Established in 2003, Infiniti Research is a leading market intelligence company providing smart solutions to address your business challenges. Infiniti Research studies markets in more than 100 countries to help analyze competitive activity, see beyond market disruptions, and develop intelligent business strategies. To know more, visit: https://www.infinitiresearch.com/about-us

Contacts

Infiniti Research

Anirban Choudhury

Marketing Manager

US: +1 844 778 0600

UK: +44 203 893 3400

https://www.infinitiresearch.com/contact-us